XBiotech Inc.XBITNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank3
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P3
Near historical low
vs 3Y Ago
-1.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-438.91%
Q3 202528.89%
Q2 202510.88%
Q1 2025-2.75%
Q4 2024-11.89%
Q3 202448.62%
Q2 2024-57.96%
Q1 2024-109.79%
Q4 2023-130.87%
Q3 202383.47%
Q2 2023-87.13%
Q1 2023-277.88%
Q4 2022335.04%
Q3 202278.65%
Q2 2022-5.15%
Q1 2022-191.25%
Q4 202148.30%
Q3 2021-104.67%
Q2 20213924.16%
Q1 2021562.66%
Q4 2020-105.23%
Q3 2020164.69%
Q2 202080.93%
Q1 2020-1519.67%
Q4 201924.84%
Q3 2019-2.49%
Q2 2019-3.98%
Q1 20198.58%
Q4 2018-28.06%
Q3 2018-2.44%
Q2 2018-10.61%
Q1 201848.20%
Q4 2017-5.27%
Q4 201723.64%
Q2 201728.89%
Q1 20176.98%
Q4 201614.75%
Q3 2016-81.99%
Q2 201617.05%
Q1 20166.99%